Article
Brain stem cells as the cell of origin in glioma
1 Jan 2014
Abstract excerpt
Glioma incidence rates in the United States are near 20000 new cases per year, with a median survival time of 14.6 mo for high-grade gliomas due to limited therapeutic options. The origins of these tumors and their many subtypes remain a matter of investigation. Evidence from mouse models of glioma and human clinical data have provided clues about the cell types and initiating oncogenic mutations that drive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
